NasdaqGS - Delayed Quote USD
CeriBell, Inc. (CBLL)
17.89
+0.39
+(2.23%)
At close: June 6 at 4:00:01 PM EDT
17.89
0.00
(0.00%)
After hours: June 6 at 4:04:03 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.4 | -0.38 | -1.54 | -1.48 |
| Low Estimate | -0.43 | -0.41 | -1.64 | -1.62 |
| High Estimate | -0.37 | -0.34 | -1.44 | -1.36 |
| Year Ago EPS | -- | -1.85 | -3.39 | -1.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 20.54M | 21.65M | 86.01M | 110.71M |
| Low Estimate | 19.13M | 21M | 85.37M | 107.75M |
| High Estimate | 21M | 22.2M | 87M | 114.7M |
| Year Ago Sales | -- | 17.2M | 65.44M | 86.01M |
| Sales Growth (year/est) | -- | 25.91% | 31.43% | 28.71% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|
| EPS Est. | -0.87 | -0.31 | -0.46 |
| EPS Actual | -1.85 | -0.4 | -0.36 |
| Difference | -0.98 | -0.09 | 0.1 |
| Surprise % | -113.24% | -27.48% | 21.17% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.4 | -0.38 | -1.54 | -1.48 |
| 7 Days Ago | -0.4 | -0.38 | -1.54 | -1.48 |
| 30 Days Ago | -0.44 | -0.4 | -1.7 | -1.41 |
| 60 Days Ago | -0.44 | -0.4 | -1.7 | -1.41 |
| 90 Days Ago | -0.44 | -0.4 | -1.7 | -1.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 2 | 3 | -- |
| Up Last 30 Days | 3 | 2 | 3 | -- |
| Down Last 7 Days | -- | 1 | -- | 3 |
| Down Last 30 Days | -- | 1 | -- | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CBLL | -- | 79.66% | 54.54% | 3.69% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Initiated | Ladenburg Thalmann: Buy | 4/4/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/26/2025 |
| Maintains | TD Cowen: Buy to Buy | 12/9/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 12/9/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/13/2024 |
| Initiated | JP Morgan: Overweight | 11/5/2024 |
Related Tickers
BBNX Beta Bionics, Inc.
19.08
-2.40%
LUNG Pulmonx Corporation
3.1700
+6.73%
NPCE NeuroPace, Inc.
13.15
-0.98%
NMTC NeuroOne Medical Technologies Corporation
0.5817
-1.24%
OM Outset Medical, Inc.
20.93
+4.34%
KIDS OrthoPediatrics Corp.
21.19
+1.58%
CVRX CVRx, Inc.
6.56
+1.55%
VPTDF Ventripoint Diagnostics Ltd.
0.0800
-6.95%
INSP Inspire Medical Systems, Inc.
136.02
+0.11%
PYNKF Perimeter Medical Imaging AI, Inc.
0.1700
+6.25%